Compare HELE & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HELE | AGMB |
|---|---|---|
| Founded | 1968 | 2017 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 643.6M | 576.2M |
| IPO Year | 1996 | 2024 |
| Metric | HELE | AGMB |
|---|---|---|
| Price | $28.28 | $8.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $31.67 | ★ $37.67 |
| AVG Volume (30 Days) | ★ 499.4K | 146.6K |
| Earning Date | 10-08-2026 | 11-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $1,478,845,000.00 | N/A |
| Revenue This Year | $0.95 | N/A |
| Revenue Next Year | $1.50 | N/A |
| P/E Ratio | $17.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.85 | $7.97 |
| 52 Week High | $31.98 | $17.82 |
| Indicator | HELE | AGMB |
|---|---|---|
| Relative Strength Index (RSI) | 55.76 | 33.05 |
| Support Level | $25.47 | $8.57 |
| Resistance Level | $30.45 | $12.53 |
| Average True Range (ATR) | 1.73 | 0.81 |
| MACD | 0.12 | -0.02 |
| Stochastic Oscillator | 52.81 | 24.19 |
Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.